Stereobody radiotherapy for nodal recurrences in oligometastatic patients: a pooled analysis from two phase I clinical trials-Reference-Cited by-同舟云学术

Stereobody radiotherapy for nodal recurrences in oligometastatic patients: a pooled analysis from two phase I clinical trials

Published:2020-06-03 Issue:4 Volume:37 Page:519-529
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Deodato Francesco,Ferro Milena,Cilla Savino,Ianiro Anna,Buwenge Milly,Re Alessia,Sallustio Giuseppina,Valentini Vincenzo,Morganti Alessio G.,Macchia Gabriella^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10585-020-10039-x.pdf

Reference46 articles.

1. Guckenberger M, Lievens Y, Bouma AB, Colette L, Dekker A, deSouza NM et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21:e18–e28. https://doi.org/10.1016/S1470-2045(19)30718-1

2. Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA et al (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14:e28–37. https://doi.org/10.1016/S1470-2045(12)70510-7

3. Milano MT, Katz AW, Zhang H, Okunieff P (2012) Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83:878–886. https://doi.org/10.1016/j.ijrobp.2011.08.036

4. de Vin T, Engels B, Gevaert T et al (2014) Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival. Ann Oncol 25:467–471. https://doi.org/10.1093/annonc/mdt537

5. Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA et al (2009) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115:665–672. https://doi.org/10.1002/cncr.24059

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Radiosurgery with Volumetric Modulated Arc Radiotherapy: Final Results of a Multi-arm Phase I Trial (DESTROY-2);Clinical Oncology;2024-10

2. Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).;Strahlentherapie und Onkologie;2024-01-05

3. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study;Clinical Oncology;2023-01

4. CARE‑compliant stereotactic radiotherapy of urothelial nodal metastases: A case report;Molecular and Clinical Oncology;2022-02-18

5. Oligometastatic disease: Adrenal, lymph nodes, bone;Advances in Magnetic Resonance Technology and Applications;2022